Somerset Indus is delighted to announce its investment in Printmann Group, further solidifying our commitment to fostering growth and innovation within the Pharma and Healthcare space, and marking the full deployment of our Fund II. The Company is a pioneer in the manufacturing of paper-based packaging products such as cartons, leaflets, labels and foils. The...Read More
“We will probably do better with low volume, by focusing on niche APIs than with high volume ones,” he said, adding that a lot of other chemical processes in the manufacturing cycle would also have to be moved to India to cut costs in the long run.Read More
A pharmaceutical formulations and API manufacturing company. Established in 2006, Globela is an established ISO, FDCA – India and WHO cGMP accredited formulations manufacturing company with multiple therapeutic areas including oncology, anti-infectives, gastro, CVS, etc. and sales presence across 30+ countries. It is an experienced manufacturer for high quality semi-finished, finished dosages formulation and active...Read More
Somerset Indus Capital Partners has picked up a minority stake in Gujarat-based Globela Pharma Pvt Ltd, marking the healthcare-focused private equity firm's first bet in the pharmaceutical space in India.Read More
